{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:40:24Z","timestamp":1793839224529,"version":"4.6.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T00:00:00Z","timestamp":1532995200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1027265"],"award-info":[{"award-number":["APP1027265"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13071-018-3022-2","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T08:37:53Z","timestamp":1533026273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Mass drug administration and the sustainable control of schistosomiasis: an evaluation of treatment compliance in the rural Philippines"],"prefix":"10.1186","volume":"11","author":[{"given":"Marianette T.","family":"Inobaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thao N.","family":"Chau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Kay","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"MacDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remigio M.","family":"Olveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica L.","family":"Tallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhoys M.","family":"Landicho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Malacad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila F.","family":"Aligato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerric B.","family":"Guevarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen G.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,31]]},"reference":[{"key":"3022_CR1","unstructured":"WHO. Schistosomiasis Progress Report (2001\u20132011) and Strategic Plan (2012\u20132020). Geneva: World Health Organization; 2013."},{"key":"3022_CR2","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) Results. Seattle: Institute for Health Metrics and Evaluation (IHME); 2017."},{"key":"3022_CR3","first-page":"749","volume":"92","author":"WHO\/Department of control of neglected tropical diseases","year":"2017","unstructured":"WHO\/Department of control of neglected tropical diseases. Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2016. Wkly Epidemiol Rec. 2017;92:749\u201360.","journal-title":"Wkly Epidemiol Rec."},{"key":"3022_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1097\/QCO.0b013e328357e4cf","volume":"25","author":"D Humphries","year":"2012","unstructured":"Humphries D, Nguyen S, Boakye D, Wilson M, Cappello M. The promise and pitfalls of mass drug administration to control intestinal helminth infections. Curr Opin Infect Dis. 2012;25:584\u20139.","journal-title":"Curr Opin Infect Dis."},{"key":"3022_CR5","volume-title":"Preventive chemotherapy in human helminthiasis: coordinated use of anthelmintic drugs in control interventions: a manual for health professionals and programme managers","author":"WHO","year":"2006","unstructured":"WHO. Preventive chemotherapy in human helminthiasis: coordinated use of anthelmintic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization; 2006."},{"key":"3022_CR6","doi-asserted-by":"publisher","first-page":"936128","DOI":"10.1155\/2012\/936128","volume":"2012","author":"L Leonardo","year":"2012","unstructured":"Leonardo L, Rivera P, Saniel O, Villacorte E, Lebanan MA, Crisostomo B, et al. A national baseline prevalence survey of schistosomiasis in the Philippines using stratified two-step systematic cluster sampling design. J Trop Med. 2012;2012:936128.","journal-title":"J Trop Med."},{"key":"3022_CR7","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.micinf.2013.07.010","volume":"15","author":"AG Ross","year":"2013","unstructured":"Ross AG, Olveda RM, Acosta L, Harn DA, Chy D, Li Y, et al. Road to the elimination of schistosomiasis from Asia: the journey is far from over. Microbes Infect. 2013;15:858\u201365.","journal-title":"Microbes Infect."},{"key":"3022_CR8","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.micinf.2014.10.006","volume":"17","author":"MT Inobaya","year":"2015","unstructured":"Inobaya MT, Olveda RM, Tallo V, McManus DP, Williams GM, Harn DA, et al. Schistosomiasis mass drug administration in the Philippines: lessons learnt and the global implications. Microbes Infect. 2015;17:6\u201315.","journal-title":"Microbes Infect."},{"key":"3022_CR9","first-page":"651","volume":"47","author":"L Leonardo","year":"2016","unstructured":"Leonardo L, Chigusa Y, Kikuchi M, Kato-Hayashi N, Kawazu S, Angeles JM, et al. Schistosomiasis in the Philippines: challenges and some successes in control. Southeast Asian J trop Med Public Health. 2016;47:651\u201366.","journal-title":"Southeast Asian J trop Med Public Health"},{"key":"3022_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1186\/s13071-015-1144-3","volume":"8","author":"D Gurarie","year":"2015","unstructured":"Gurarie D, Yoon N, Li E, Ndeffo-Mbah M, Durham D, Phillips AE, et al. Modelling control of Schistosoma haematobium infection: predictions of the long-term impact of mass drug administration in Africa. Parasit Vectors. 2015;8:529.","journal-title":"Parasit Vectors."},{"key":"3022_CR11","doi-asserted-by":"publisher","first-page":"e2447","DOI":"10.1371\/journal.pntd.0002447","volume":"7","author":"A Krentel","year":"2013","unstructured":"Krentel A, Fischer PU, Weil GJ. A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis. PLoS Negl Trop Dis. 2013;7:e2447.","journal-title":"PLoS Negl Trop Dis."},{"key":"3022_CR12","volume-title":"Crossing the billion. Lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmited helminthiases and trachoma: preventive chemotherapy for neglected tropical diseases","author":"WHO","year":"2017","unstructured":"WHO. Crossing the billion. Lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmited helminthiases and trachoma: preventive chemotherapy for neglected tropical diseases. Geneva: World Health Organization; 2017."},{"key":"3022_CR13","unstructured":"WHO Preventive Chemotherapy and Transmission Control Databank. \n                    http:\/\/www.who.int\/neglected_diseases\/preventive_chemotherapy\/databank\/en\/index.html\n                    \n                  ; 2017. Accessed 15 June 2018."},{"key":"3022_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s13071-017-2206-5","volume":"10","author":"SH Farrell","year":"2017","unstructured":"Farrell SH, Truscott JE, Anderson RM. The importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission. Parasit Vectors. 2017;10:291.","journal-title":"Parasit Vectors."},{"key":"3022_CR15","doi-asserted-by":"publisher","first-page":"e0123673","DOI":"10.1371\/journal.pone.0123673","volume":"10","author":"D Tuhebwe","year":"2015","unstructured":"Tuhebwe D, Bagonza J, Kiracho EE, Yeka A, Elliott AM, Nuwaha F. Uptake of mass drug administration programme for schistosomiasis control in Koome Islands, Central Uganda. PLoS One. 2015;10:e0123673.","journal-title":"PLoS One"},{"key":"3022_CR16","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/trstmh\/tru057","volume":"108","author":"BV Babu","year":"2014","unstructured":"Babu BV, Babu GR. Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review. Trans R Soc Trop Med Hyg. 2014;108:538\u201349.","journal-title":"Trans R Soc Trop Med Hyg."},{"key":"3022_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13071-015-1244-0","volume":"9","author":"S Knopp","year":"2016","unstructured":"Knopp S, Person B, Ame SM, Ali SM, Muhsin J, Juma S, et al. Praziquantel coverage in schools and communities targeted for the elimination of urogenital schistosomiasis in Zanzibar: a cross-sectional survey. Parasit Vectors. 2016;9:5.","journal-title":"Parasit Vectors."},{"key":"3022_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1093\/cid\/civ829","volume":"62","author":"GF Chami","year":"2016","unstructured":"Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, Dunne DW. Profiling nonrecipients of mass drug administration for schistosomiasis and hookworm infections: a comprehensive analysis of praziquantel and albendazole coverage in community-directed treatment in Uganda. Clin Infect Dis. 2016;62:200\u20137.","journal-title":"Clin Infect Dis."},{"key":"3022_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.socscimed.2017.04.009","volume":"183","author":"GF Chami","year":"2017","unstructured":"Chami GF, Kontoleon AA, Bulte E, Fenwick A, Kabatereine NB, Tukahebwa EM, Dunne DW. Community-directed mass drug administration is undermined by status seeking in friendship networks and inadequate trust in health advice networks. Soc Sci Med. 2017;183:37\u201347.","journal-title":"Soc Sci Med."},{"key":"3022_CR20","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1186\/s12889-016-3662-0","volume":"16","author":"GO Odhiambo","year":"2016","unstructured":"Odhiambo GO, Musuva RM, Odiere MR, Mwinzi PN. Experiences and perspectives of community health workers from implementing treatment for schistosomiasis using the community directed intervention strategy in an informal settlement in Kisumu City, western Kenya. BMC Public Health. 2016;16:986.","journal-title":"BMC Public Health"},{"key":"3022_CR21","first-page":"335","volume":"63","author":"HJ Liwanag","year":"2017","unstructured":"Liwanag HJ, Uy J, Bataller R, Gatchalian JR, De La Calzada B, Uy JA, Dayrit M. Soil-transmitted helminthiasis and schistosomiasis in children of poor families in Leyte, Philippines: lessons for disease prevention and control. J Trop Pediatr. 2017;63:335\u201345.","journal-title":"J Trop Pediatr."},{"key":"3022_CR22","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2471\/BLT.07.047563","volume":"86","author":"VL Tallo","year":"2008","unstructured":"Tallo VL, Carabin H, Alday PP, Balolong E Jr, Olveda RM, ST MG. Is mass treatment the appropriate schistosomiasis elimination strategy? Bull World Health Organ. 2008;86:765\u201371.","journal-title":"Bull World Health Organ."},{"key":"3022_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/infdis\/jiu416","volume":"211","author":"AG Ross","year":"2015","unstructured":"Ross AG, Olveda RM, Chy D, Olveda DU, Li Y, Harn DA, et al. Can mass drug administration lead to the sustainable control of schistosomiasis? J Infect Dis. 2015;211:283\u20139.","journal-title":"J Infect Dis."},{"key":"3022_CR24","unstructured":"National Collaborating Centre for Primary Care (UK). National Institute for Health and Clinical Excellence: Guidance. In: Medicines Adherence: Involving Patients in Decisions About Prescribed Medicines and Supporting Adherence. London: Royal College of General Practitioners (UK); 2009."},{"key":"3022_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijid.2016.09.025","volume":"54","author":"AG Ross","year":"2017","unstructured":"Ross AG, Olveda RM, McManus DP, Harn DA, Chy D, Li Y, et al. Risk factors for human helminthiases in rural Philippines. Int J Infect Dis. 2017;54:150\u20135.","journal-title":"Int J Infect Dis."},{"key":"3022_CR26","doi-asserted-by":"publisher","first-page":"e1001640","DOI":"10.1371\/journal.pmed.1001640","volume":"11","author":"S Muhumuza","year":"2014","unstructured":"Muhumuza S, Olsen A, Katahoire A, Kiragga AN, Nuwaha F. Effectiveness of a pre-treatment snack on the uptake of mass treatment for schistosomiasis in Uganda: a cluster randomized trial. PLoS Med. 2014;11:e1001640.","journal-title":"PLoS Med."},{"key":"3022_CR27","doi-asserted-by":"publisher","first-page":"e0006043","DOI":"10.1371\/journal.pntd.0006043","volume":"11","author":"M Burnim","year":"2017","unstructured":"Burnim M, Ivy JA, King CH. Systematic review of community-based, school-based, and combined delivery modes for reaching school-aged children in mass drug administration programs for schistosomiasis. PLoS Negl Trop Dis. 2017;11:e0006043.","journal-title":"PLoS Negl Trop Dis."},{"key":"3022_CR28","doi-asserted-by":"publisher","first-page":"e0003108","DOI":"10.1371\/journal.pntd.0003108","volume":"9","author":"CA Gordon","year":"2015","unstructured":"Gordon CA, Acosta LP, Gobert GN, Jiz M, Olveda RM, Ross AG, et al. High prevalence of Schistosoma japonicum and Fasciola gigantica in bovines from northern Samar, the Philippines. PLoS Negl Trop Dis. 2015;9:e0003108.","journal-title":"PLoS Negl Trop Dis"},{"key":"3022_CR29","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1017\/S0950268814002581","volume":"143","author":"H Carabin","year":"2015","unstructured":"Carabin H, Mc GS, Sahlu I, Tarafder MR, Joseph L, BB DEA, et al. Schistosoma japonicum in Samar, the Philippines: infection in dogs and rats as a possible risk factor for human infection. Epidemiol Infect. 2015;143:1767\u201376.","journal-title":"Epidemiol Infect."},{"key":"3022_CR30","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2049-9957-2-11","volume":"2","author":"A Dabo","year":"2013","unstructured":"Dabo A, Bary B, Kouriba B, Sankare O, Doumbo O. Factors associated with coverage of praziquantel for schistosomiasis control in the community-direct intervention (CDI) approach in Mali (West Africa). Infect Dis Poverty. 2013;2:11.","journal-title":"Infect Dis Poverty."},{"key":"3022_CR31","doi-asserted-by":"publisher","first-page":"e63438","DOI":"10.1371\/journal.pone.0063438","volume":"8","author":"S Muhumuza","year":"2013","unstructured":"Muhumuza S, Olsen A, Katahoire A, Nuwaha F. Uptake of preventive treatment for intestinal schistosomiasis among school children in Jinja district, Uganda: a cross sectional study. PLoS One. 2013;8:e63438.","journal-title":"PLoS One."},{"key":"3022_CR32","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1080\/20786190.2014.978121","volume":"57","author":"A Randjelovic","year":"2015","unstructured":"Randjelovic A, Fr\u00f8n\u00e6s SG, Munsami M, Kvalsvig JD, Zulu SG, Gagai S, et al. A study of hurdles in mass treatment of schistosomiasis in KwaZulu-Natal, South Africa. South Afr Fam Pract. 2015;57:57\u201361.","journal-title":"South Afr Fam Pract"},{"key":"3022_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12639-014-0454-2","volume":"40","author":"OT Salawu","year":"2016","unstructured":"Salawu OT, Odaibo AB. Schistosomiasis transmission; socio-demographic, knowledge and practices as transmission risk factors in pregnant women. J Parasit Dis. 2016;40:93\u20139.","journal-title":"J Parasit Dis."},{"key":"3022_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2471\/BLT.17.198879","volume":"96","author":"JF Friedman","year":"2018","unstructured":"Friedman JF, Olveda RM, Mirochnick MH, Bustinduy AL, Elliott AM. Praziquantel for the treatment of schistosomiasis during human pregnancy. Bull World Health Organ. 2018;96:59\u201365.","journal-title":"Bull World Health Organ."},{"key":"3022_CR35","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.4269\/ajtmh.2012.12-0435","volume":"87","author":"MO Omedo","year":"2012","unstructured":"Omedo MO, Matey EJ, Awiti A, Ogutu M, Alaii J, Karanja DM, et al. Community health workers\u2019 experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE Project. Am J Trop Med Hyg. 2012;87:1065\u201372.","journal-title":"Am J Trop Med Hyg."},{"key":"3022_CR36","doi-asserted-by":"publisher","first-page":"e0004814","DOI":"10.1371\/journal.pntd.0004814","volume":"10","author":"B Person","year":"2016","unstructured":"Person B, Ali SM, A'Kadir FM, Ali JN, Mohammed UA, Mohammed KA, et al. Community knowledge, perceptions, and practices associated with urogenital schistosomiasis among school-aged children in Zanzibar, United Republic of Tanzania. PLoS Negl Trop Dis. 2016;10:e0004814.","journal-title":"PLoS Negl Trop Dis"},{"key":"3022_CR37","doi-asserted-by":"publisher","first-page":"e728","DOI":"10.1371\/journal.pntd.0000728","volume":"4","author":"PT Cantey","year":"2010","unstructured":"Cantey PT, Rout J, Rao G, Williamson J, Fox LM. Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs. PLoS Negl Trop Dis. 2010;4:e728.","journal-title":"PLoS Negl Trop Dis."},{"key":"3022_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.inhe.2010.12.001","volume":"3","author":"ZT Nujum","year":"2011","unstructured":"Nujum ZT. Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India. Int Health. 2011;3:22\u20136.","journal-title":"Int Health"},{"key":"3022_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1473-3099(15)00345-X","volume":"16","author":"RM Olveda","year":"2016","unstructured":"Olveda RM, Acosta LP, Tallo V, Baltazar PI, Lesiguez JL, Estanislao GG, et al. Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2016;16:199\u2013208.","journal-title":"Lancet Infect Dis."},{"key":"3022_CR40","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1017\/S0031182009990709","volume":"136","author":"FM Fleming","year":"2009","unstructured":"Fleming FM, Fenwick A, Tukahebwa EM, Lubanga RG, Namwangye H, Zaramba S, Kabatereine NB. Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programme. Parasitology. 2009;136:1759\u201369.","journal-title":"Parasitology."}],"container-title":["Parasites & Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-3022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-018-3022-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-018-3022-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T09:39:50Z","timestamp":1568972390000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-018-3022-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,31]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3022"],"URL":"https:\/\/doi.org\/10.1186\/s13071-018-3022-2","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,31]]},"assertion":[{"value":"3 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Institutional Review Boards of the Research Institute for Tropical Medicine - Department of Health (IRB Protocol Code 2014-22-0), the Philippines and Griffith University, Australia.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"441"}}